GENOMICS AND ITS EFFECT ON BASIC SCIENCE
The catalyst for the explosion of genetic knowledge was the initiation of the international Human Genome Project in 1990. Funded in the United States by the National Institutes of Health and the Department of Energy, the mission of the 15-year Human Genome Project was to discover the complexities of chromosomes and the genes withinthem,and the organization of genesand how theyaffecthumanhealth. Currently, scientists are learning to "read" DNA sequences, discovering the normalfunctions of manygenes,and developing the ability to usegeneticinformation. The ultimate purposeof the Human GenomeProjectis to fosterresearch and develop therapeutics to combathumandisease (Baltimore, 2001) .The Sidebaron page535 provides a summary of someof the most important scientific outcomes of the Human Genome Project (International Human Genome Sequencing Consortium, 2001) . The Sidebaron page 536 highlights some of the current and future genomic research efforts.
As the HumanGenome Projectgoalsare accomplished, the understanding of normalbiology is changing. Knowledge of genetic conditions goes beyond describing known syndromesand symptomatic characteristics. Genetic signals provide controls for all humandevelopment, structural integrity,
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andregulatory processes throughout life . Failure of theseprocesses in the embryoresults in miscarriages or birthdefects. Failure of one or moregenetic processes in adults results in illness, aging, and death. Tobetterunderstand the role of genetics in health and illness, a review of some basicprinciples is necessary.
THE WORLD OF MOLECULAR GENETICS
The principles of deoxyribonucleic acid (DNA) structure, micro-packaging of theDNAmolecule, genepenetrance, classicpatterns of inheritance and biologic diversity, and heterogeneity are particularly relevant to nurses who encounter clients and families with genetic questions. Understanding these principles assists nurses in determining appropriate assessment and testing, the historical and clinical information thatshouldaccompany anydiagnostic request, andthe typeof counseling needed.
DNA Structure and the Biology ofInheritance
A central genetic concept is the.use of a series of base pairs to construct DNA. Bases are composed of four chemicals-adenine (A), thymine (T), guanine (G), and cytosine (C) . These chemicals are paired in a specific way so that A always pairs with T in DNA or with uracil (U) in ribonucleic acid (RNA). G always pairs with C. These pairs give humans the "blueprint for life" specificfor the species and unique for each individual. It is the order of the bases that provides the exact code for buildingeach protein in the body, whether it is a structural protein, an enzyme, a hormone, or part of the immune system. Change the order of the bases with additions, deletions, or single base substitutions and the message is changed within the protein building code. The alterations in the genetic code are referred to as polymorphisms and mutations. Polymorphisms are alternate forms of a gene that, under most circumstances, do not change the function of the gene. Mutations are alterations in the genetic code that change the function of a particular gene. The Sidebar on page 537 provides a glossary of important genetic terms (Gelehrter, Collins, & Ginsburg, 1998; Lewis, 2005; Nussbaum, Mclnnes, & Willard, 2004) .
Micropackaging ofGenetic Information
Oncetheorderof basesisdetermined, thegenetic material must be packaged to allow an enormous amount o~~onna tionto be compacted intoa very small space. The 3 billion base pairs that makeup the humangenome are spuninto strands of DNA. DNA contains 25,000 to 30,000 protein coding human genes(exons) and longstretches of non-coding DNA(introns). Mostgenetic research has focused on theprotein c<x;Iing ge?es. Scientists currently arediscovering thatthenon-coding regions are alsoimportant and maycontrol critical regulatory functions (Human GenomeProject Information, 2004) .
Each strand of DNA is spun into threads on a histone protein "spool" that is then stacked in groups of eight and furthercompacted to fit into 46 chromosomes (23 pairs). Because the DNA in any cell would stretch for 6 feet, complex micro-packaging is essential becausea vastamountof genetic material must fit into the nucleus of everycell. DNA must be packaged in a way that allowsstructural and regulatory genes to be turned on and off as needed throughout the life span (Gelehrter et al., 1998) .
Penetrance
Another important genetic concept is penetrance. Although many individuals may. carry a particular gene mutation, it may not be expressed In all cases. Some genes, such as the gene for Huntington's disease, are fully expressed. If one inherits the Huntington gene and lives to the age that the gene would normally express itself, that individual will develop Huntington's disease. Other genes may only make an individual predisposed to develop a given problem, but the diseasemay neveractually develop. For example, having the breastcancergene (BRCA1) increases an individual's risk for earlyonsetbreastcancer, but the gene may not expressunless other factors-ethnicity, the interaction with other genes, or lifestyle factors-are present (Lewis, 2(05) .
Classic Panerns ofInheritance
Nurses frequently recognize a potential geneticproblem in a client or family while completing a family history. In somecases,the nursewillnoticea particular patternof inheritance.Patterns of inheritance fall into four majorgroups, with subgroups under each category. These includechromosomal disorders, singlegene disorders, multifactorial disorders, and mitochondrial conditions. Chromosomal disorders accountfor approximately 1% of all genetic disorders and includeDown and Turnersyndromes. In adults, chromosome translocations can cause multiple miscarriages in otherwise healthycouples. Single gene disorders (Mendelian inheritance) include more than5,000 syndromes and follow classicdominant, recessive, and X-linkedpatterns of inheritance.
Complexor multifactorial disorders are those conditions that result from several genes interacting with environmental triggers. These accountfor the vastmajority of commonadult onset health problems, such as cancer, stroke, heart disease, typeI diabetes, and otherchronichealthproblems. Inheritance patterns may not be as striking in complex (multifactorial) disorders becausethese conditions depend on many different interactive factors. A family membermightbe predisposed to the condition, but was asymptomatic at the time a history was obtained (Nussbaum et al., 2004) . 
Goals of the Human Genome Project
Generate a high-quality reference DNA sequence to identify all human genes:
• Completed inApril of2003, 2 years ahead ofschedule.
• Spawned hundreds of other genome sequence projects sothat microbes, plants, and animals can be compared.
Understand basic biology ata molecular level:
• The human genome contains 3 billion chemical nucleotide bases (A,G,T,C). • The average gene has 3,000 bases, but genes vary greatly with the largest known gene, dystrophin, having 2.4 million bases. • The total number of genes is estimated atapproximately 25,000 to 30,000, much lower than previous estimates of 80,000 to 140,000 genes. • 99.9% of nucleotide bases are exactly the same for all individuals. • The functions are unknown for more than 50% of discovered genes.
Identify DNA sequences and variations responsible for regulating cellular functions.
Understand how genes, proteins and other molecules work together to create complex living organisms.
Adapted from Human Genome Project Information (2004); MyDNA (2004) .
Some genesare not found in the nucleus, but are located in the cytoplasm in energy producing organelles called mitochondria. Because the cytoplasm in the embryo comes from the ova and not the sperm, mitochondrial genes are passed from the mother to all of her children. Mitochondrial gene mutations producea variety of problems, including neurodegenerative diseases, muscle diseases, and encephalopathies. Some of these genes are becoming important in chronic diseases such as type Il diabetes. As more is learned about geneticsat a molecularlevel, other nontraditional patternsof inheritance are emerging (Lewis, 2(05) .
Biologic Diversity and Heterogeneity
It is an axiom in biology that hybrid species are healthier than inbred species. Because homozygosity (genetic sameness) leads to extinction, all of nature is designed to foster biologic diversity.The term used most frequently to describe the biologic diversity within genes is heterogeneity. Genetic heterogeneity means that different mutations at the same gene locus (allelic heterogeneity) or from different locations within the gene (locus heterogeneity) can produce the same clinical expression (phenotype) in individuals (Gelehrter, 1998) . Heterogeneity is promoted by inheriting alternate forms of the same gene (alleles) from each parent. Heterogeneity is further fostered by crossing over, independent assortment, and other mechanisms during meiosis. Mutations can happen as DNA is being copied and errors occur. These errors alter the genetic code in a given individual. Some will be corrected but others may persist over time (Lewis, 2005) . Manymutations thatpersistare onesthatprovidea selective advantage to an environmental factor. A classicexample of genetic heterogeneity is variability in hemoglobin types. For a given individual, hemoglobin type is coded by two alleles (alternate forms of the same gene).In the world's population, however, there are more than 400 known hemoglobin alleles. Thesevariations havedeveloped overtimein response to changing environmental conditions. In hemoglobin, the catalystfor these alterations is the presenceof malaria. These variations were protective, and many carrierssurvived while individuals with "normal" hemoglobin A died. Subsequent migrations of individuals resulted in many possible combinations for a given mating (Sickle Cell Information Center, 2004a,b) .
In the workplace, hemoglobinopathy screening should be offeredto individuals froma variety of ethnicbackgrounds. The minimum test should be hemoglobin electrophoresis to identify not only hemoglobin S, found in individuals from Africa and other equatorial regions where malaria is prevalent, but also hgb C that is frequent in individuals of African descent; hgb D that is frequentin individuals from India and the MiddleEast;hgb E that is frequent in individuals of Asian descent; thalassemia that is frequent in Italian, Greek, and Southern European individuals. Previously used spot testsare inadequate. With increasing numbers of immigrants from all over the world in the American workplace, it is important to considerhemoglobin variation wheneveranemiais present.
More AboutPolymorphisms
In the past, polymorphisms were thought to be harmless variations. Currently, it is known that although polymorphisms may function normally under many circumstances, polymorphic variations can affect the body's responses to a 536 given stimuli. This knowledge, especially related to single base pair changes, has revolutionized the understanding of gene and environment interactions.
A majorexampleis the variable responses to pharmaceuticals. Nurseshavelongrecognized thatclientsreactdifferently to the same drug. Givenan identical compound in exactly the same dose, some individuals will develop a toxic overload whileotherswill not reach a therapeutic level. Stillother individuals will have extraordinary allergic reactions. These variations are frequently familial. Studies of molecular~enet ics have determined that most of these variations are caused by a singlebasepairchangecalledsinglenucleotide polymorphisms (SNP). SNPs alter the gene just enough to regulate drug metabolism. OtherSNPs affectdrug transport, signaling pathways, or responses at the cellularlevel. An entirely new field of genetics, pharmacogenetics, is devoted to studying ways in which an individual's natural genetic variations affect the body's response to a given drug. The term pharmacogenomics refers to the application of genomic technology to drug development. VIrtually all new medications are being developed usingpharmacogenornics. Examining basepairsequences and SNPs allow researchers to account for genetic variations early in clinical trials. This reduces the numberof untoward effects by identifying those individuals who should not receive a particular drug. In the near future, "SNP maps" willbe used to testindividual responses beforea medication is prescribed (Nicol, 2003) . No longerwillclientsbe treatedfor hypertension or hypercholesterolemia by trialand error. In the future, blood tests will determine the most effective medication and reduceside effects.
COMMON EXAMPLES OF HETEROGENEITY FOR THE OCCUPATIONAL HEALTH NURSE

Hypercholesterolemia and Hyperlipidemia
Some of the mostcommongene mutations are thosethat controlcholesterol and lipidaccumulation in the cells.Ifthere is a pool of cholesterol in hepatocytes, the genes for low-density lipoprotein (LDL)receptors will notbe turnedon and the plasma level of LDL will remain high. If there is a decrease in hepaticcholesterol, the LDL receptorgenes will be stimulatedand cholesterol will be removed from the plasma.There are manysteps,all undergeneticcontrol, that determine if the message is transmitted from blood to the liver cell. A mutationin anyof thesestepsmaycauseelevated cholesterol levels (Nabel, 2003; Scriver, Beaudet,Sly,& Valle, 1995) .
Four single gene diseases elevate plasma levels ofLDL by impairing the activity of hepatic LDL receptors. Familial hypercholesterolemia was the first to be described. In that form, a lack of sufficient LDL receptors causes the buildup of cholesterol and results in coronary heart disease. Elevated cholesterol in this disorder is directly related to receptor cells signaling the need for more cholesterol production (Nabel, 2003) .
Familial hypercholesterolemia is an autosomal dominant disorder witha gene frequency of 1 in 500 individuals. However,more than600 mutations existWithin the familial hypercholesterolemia gene. Heterozygous individuals (one normal and one mutantallele)have half the numberof receptors and haveplasmalevels two to threetimes normal. They are at risk for early onset heart attacks. Homozygous individuals (I in a million individuals) withtwomutant alleles havesevere coronaryathrosclerosis and usually die fromheartattacks in childhood (Scriver et al., 1995) .
Mutations of the APOB-l00 gene produce changes that slowthe clearance of plasmaLDL and resultin elevated cholesterollevels. Deleterious APOB-1OO gene mutations have a gene frequency of 1 in 1,000 individuals and produce lipid profiles andclinical disease similarto individuals whoareheterozygous for familial hypercholesterolemia.
The third and fourth single gene disorders are rare and autosomal recessive. In sitosterolemia, several mutations cause a loss of function and diminished cholesterol absorption. In autosomal recessive hypercholesterolemia, there are defects in a hepatic adaptor protein that fails to clear plasma LDL.This leadsto an LDL level of 6 to 10timesnormal and veryearlydeath (Nabel, 2(03) .
.Elevated cholesterol is common. The gene frequency is high for familial hypercholesterolemia, familial liganddefective apolipoprotein B-1OO, and other clearly inherited cholesterol syndromes. Each disorder has many mutations. Virtually all individuals affected with these syndromes will require medication as well as dietary modification and longterm follow up. In addition, poorly understood susceptibility and modifier genes combine with high-fat diets to produce almostall cases of elevated cholesterol in the general public. Adequate cholesterol screening anda thorough genetic family history isessential whenever cholesterol andlipidscreening is undertaken (Scriver et al., 1995) .
Type II Diabetes
Type II diabetes is an excellent example of a complex disorder with multiple genetic influences interacting with environmental factors. Diabetes is reaching epidemic proportions with more than 194 million individuals affected worldwide. In North America alone there were more than 16 million individuals ages 20 to 79 with diabetes, and 95% of these clients have type II diabetes. Diabetic complications, such as heart disease, stroke, kidney damage, retinopathy, neuropathy and skin complications, are increasing in the workplace as the population ages. Part of this increase is associated with Western lifestyle. Type II diabetes often begins with insulin resistanceand is strongly associated with obesity. The onset is frequently after age 40 as the pancreas loses its ability to produce insulin over time. Type II diabetes is extremelyheterogeneousand there is substantialevidenceof genetic influences in this disorder (International Diabetes Federation, 2005; Lamb, 2005) .
A positive family history increases the risk 2.4 fold, and if a parentis affected the child has a 38% lifetime risk of developing typeII diabetes. If bothparents havetypeII diabetes, the prevalence in offspring is 60%. Studies of identical twins show an 88% concordance rate. Molecular genetic evidence is evenmoreimportant to researchers seeking newtreatments for diabetes. Candidate regions for genesassociated withdiabetes have been mapped to chromosomes I, 2, 3, 4, 11,and 12.Twoof the mostimportant willbe discussed (Kaprio et al., 1992; Lamb,2005; Pierce, Keen, & Bradley, 1995) .
One of the most strongly linked genes associated with typeIIdiabetes is Calpain-I O. It mapsto thelongarmof Chromosome 2 and is foundin morethan 10%of Mexican Americans affected with type II diabetes. It seems to have a role in insulin signaling and secretion and alsoregulates the function of otherproteins. Variations in Calpain-I 0 can increase or decrease risk for type II diabetes. Two combinations of highrisk variants confer a three-fold increased risk for diabetes in Mexican Americans. Thiscombination is alsofound in British studies and in SouthAmerican Indian and African American populations. The samevariant witha different allelecombination has beenfoundin Pima Indians, another high-risk group, and in several European populations (Horikawa et al.,2000) .
A secondgene, KCNJ1I, encodes for a subunit of glucose ATP pathway that regulates insulin secretion from pancreatic Betacells.A variant of thatgenewitha singleneucleotide change(gag-aag) is associated with type II diabetes. It is found in 18%of individuals withtypeII diabetes compared to 10.5% of controls. Insulin secretion is reduced in individuals witha normal andvariant combination, aswellas inthosewho have a variant/variant genotype. The variant/variant genotype impairs insulin secretion and is particularly destructive in individuals witha highcaloric dietandreduced physical activity (Nielsen et al.,2003; Riedel, Steckley, & Light, 2005) . These areonlytwoof manygenesthatinteract withthe environment to produce the phenotype of typeII diabetes.
There are also differences in the ways that individuals express a givengene.At a genetic level, expression of a gene is controlled by therateof its transcription from DNAto messenger RNA. In addition, genes are not expressed equally in every type of cell. At a molecular level, every case of type II diabetes results from a different combination of genetic and environmental factors. At a clinical level, a diagnosis describes a phenotype, not a genotype. In the molecular era,new prevention and treatment techniques will require a better understanding of individual genotypes.
A newmicroarray technology is beingdeveloped to supportgeneexpression studies of thousands of genessimultaneously. Because gene expression in skeletal muscle resulting in insulin resistance is the earliest detectable abnormality in individuals at riskfortypeII diabetes, microarray studies have been used to detectgene expression variations in clients with type II diabetes, a family history of diabetes, and no family 538 history of diabetes. From these studies, preventive screening methods and early identification of at-risk individuals may emerge (Patti et al., 2003) .
Pesticides and the PON1 Gene
An example of genetic polymorphisms interacting with environmental factors in the workplace is the interaction between environmental exposures to organophosphate pesticides (OPs), especially chlorpyrifos, and polymorphisms in the PONI gene. Paraoxonase (PONI) is an enzyme group regulated by the PON gene.Thesegenesare involved in lipid metabolism and inthemetabolism of OP pesticides. Thereare several forms of PON,but the genetic variations in the PONI gene play the most significant role for agricultural and other workers because it is this pathway that detoxifies exogenous exposures to pesticides. The gene has variations (polymorphisms) that enhance or reduce its regulatory abilities. This has major clinical implications for farm workers, landscapers, and others who handle chlorpyrifos and other pesticides (Battuello, Fenske, Furlong, Austin, & Burke, 2002; Online Mendelian Inheritance in Man, 2005) .
The use of pesticides has important economic implications. OPs are one of the widely used classes of pesticides to control both foliage and soil-borne insects on a variety of vegetable, fruit, and graincrops. The useof pesticides suchas chlorpyrifos prevents a monetary lossof more than$9 billion eachyearfor the agricultural industry. Approximately 24 million poundsof chlorpyrifos are used each year in the United States. OPs, however, inhibitthe enzyme cholinesterase. OP toxicity cancausesymptoms ranging fromshortness ofbreath, ataxia, nausea, diarrhea, muscle weakness, and headache to bradycardia, respiratory failure, and death (Environmental Protection Agency, 2000; Blondell, 1999; Pesticide Incident Reporting andTracking, 2000) .
The epidemiology of pesticide poisonings in the United States is poorly understood, but as early as 1990 the World Health Organization estimated 3 million individuals suffered pesticide poisonings worldwide withpossibly 220,000 deaths. Cholinesterase testing is used to measure levels of toxicity. Earlydata from California indicate that 23% of workers providing pesticide applications had reduced cholinesterase levels indicating pesticide overexposure. In a clinic-based study in North Carolina, 12% of farm workers had low levels of cholinesterase compared to 0% of non-farm workers (Ames et al., 1989; Ciesielski, Loomis, Mims,& Auer, 1994; World HealthOrganization, 1990) .
Genetic influences are important becauseafterOPs such as chlorpyrifos are absorbed into the body, they must be biotransfomed and detoxified by the liver to make them water soluble for excretion by the kidneys. This involves a series of genetically controlled enzymes in the liverand blood. Therefore, if workers have a gene variation that reduces the rate at whichtheenzymecan detoxify, theresultis increased toxicity for the worker with that polymorphism (Rozman & Klassman, 1996) .
The PON1 gene is found on Chromosome 7 and it has polymorphisms at two important places-position 192where a change in a singleamino acid controls catalytic efficiency, andpromoter mutations at thebeginning of thegenethatregulates enzymeexpression. Individuals with polymorphisms in theseareascanbe 60timesmoresusceptible topesticide toxicity. Anotherimportant variation is the developmental progression of paN1 enzymes. Because PON enzymelevels do not approach adultlevels until approximately Iyearof age,fetuses and infants havea greaterriskof neurotoxicity fromOP exposure.This is a critical problem for manyfarmworkers whose houses are in close proximity to fields that are sprayed with pesticides. Several otherpathways for metabolism of chlorpy-rifosandotherOPsexistincluding PONenzymegroups2 and 3,carboxylesterase enzymes, and cytochrome P450enzymes. The paN groups and cytochrome P450 enzymes each have many polymorphisms, so a vast numberof combinations influencing dose response and riskof toxicity are possible for a particular individual (Battuello et al., 2002; Hirvonen, 1997) .
Methods havebeendeveloped totestfor genetic polymorphisms. The question is "Do occupational health nurses want to use genetic tests that may result in discrimination against workers?" EPA standards should be settoprotect themostvulnerable. Genetic tests should only be used to identify susceptibility and develop ways to protect vulnerable workers. The current genetic nondiscrimination legislation is not comprehensive or implemented equally fromstateto state. At present, no federal or statelawsprohibit employers fromusinggenetic tests to influence employment or benefit decisions. This is especially problematic for migrant farm workers or recent immigrants who may not be aware of government policies and protections (Kaufmann, 1999; Richter & Furlong, 1999) .
Occupational health nurses shouldbe aware of the need for appropriate genetic anti-discrimination legislation because in thepasttherehasbeendiscrimination because of sicklecell trait and inappropriate use of chromosome testing in the oil industry. Because all workers need protection, not just those withpolymorphisms, themosteffective protection forindividuals with PONI gene variations would be to amend existing exposure standards basedon literature available aboutpaN1 susceptibility and to monitorall workers withlaboratory cholinesterase testing. The employer shouldprovide baseline and periodic testing and adequate follow up for workers exposed to pesticides. Employer-mandated genetic testing to findpolymorphisms is not necessary. Because protective clothing and equipment can reducethe riskof pesticide toxicity in all populations, occupational health nurses should educate workers aboutpotential risk,recognition of symptoms of toxicity, and waysto avoid excessive exposure.
THE EFFECT OF GENOMICS ON OCCUPATIONAL HEALTH PRACTICE
Family History in a Molecular Genetic Era
As technology has advanced, family history has become much more important. There is so much variety within genes thatit is not possible to develop one genetic testfor a disorder that will meet the needsof an entirepopulation. Most current genetic tests and future tests will depend on specific history and clinical information from withina particular family unit. Pedigree formats are neededto showthe relationship between family members. The yes/no checklist formatis not adequate for the molecular genetic era.
A family history willindicate mostdiseases for whichan individual has an increased risk.This becomes significant for both prevention and earlyintervention. For example, a young DECEMBER 2005, VOL. 53, NO. 12 adultwitha family history of colonpolyps shouldhavea colonoscopy every 1 to 2 yearsinstead of every 10 years. TIming of a colonoscopy might also varydepending on the cell type of the polyp seen in a given family. Early onset myocardial infarction in a client's father might indicate the need for a comprehensive cholesterol andlipidprofile. A comprehensive family history might also indicate the presence of polymorphisms that alter the way family members react to certain medications or typesof anesthesia.
Developing a pedigree format for history taking is the . mosteffective wayto trackcommondisorders suchas cancer, familial hypercholesterolemia, hypertension, and type IT diabetes because it demonstrates the relationship between family members and can be used to identify specific patterns of inheritance. Forthis reason the U.S.Surgeon General'soffice in cooperation with the Centers for Disease Control and Prevention aredeveloping an onlinemethodfor families to begin to develop their own pedigrees. Development of this tool is ongoing. The American Medical Association (2004) 
Genetic Testing
As has been discussed, gene variability will affect the way genetic testing will be used, including few populationbasedtests. Mosttestswilldependon the identification of risk factors from family history or physical assessment and the interpretation of genetic variables or laboratory values. What should the practitioner know about the benefits and risks of genetic testing, genetic manipulation, andtherapeutic modalities? There are four steps to being an effective occupational health nursein the genetic era: • Distinguish screening modalities and diagnostic tests. • Knowthe types of genetic testsneededfor a specific client population. • Use genetic resources. • Leam the ethical, social, and legal implications of a genetic condition or test.
Distinguish Screening Modalities and Diagnostic Tests. Foranygiventest, nurses needtoknowif thetestis a screening modality or a true genetic diagnostic test. Screenings should sort individuals withan elevated risk for a given problemand willalways require otherfollow-up tests. An example of a geneticscreening is serumalpha-feto-protein (AFP)screening in pregnant women. AFP is a highlyaccurate testfor measuring the amountof AFP in a pregnant woman'splasmafor a given gestational week.It is a screening testthathasa 95%detection rate for spinabifida, the condition for which the test was developed. However, AFP onlydetects 40% of Downsyndrome cases.EvenwhenAFP is combined withotheranolytes, such as humanchorionic gonadotropin andestriol, thetestonlyhas a 70% detection ratefor Downsyndrome. This is not because the test is inadequate, but because some Down syndrome fetuses make enough AFP to fall into the normal range. AFP with all of the additional anolytes is an adequate screening to separate womenat high-risk and those at low-risk. It is not a diagnostic test and should never substitute for chromosome analysis diagnostic for Downsyndrome. KlWW the Types of Genetic Tests Needed for a Specific Client Population. As the numberof tests increases, it is impossible to have one list that will be accurate under all circumstances. It is best to think of the most likely categories in specific clinical settings andcontact genetic laboratories or university genetic centers for particular protocols. It is essentialto develop a listof genetic laboratories withcontact names and phone numbers and call whenever a question about an available genetic testarises. Genetic testsare frequently being modified and newtestsare becoming available. Occupational health nurses shouldcontact theirgenetic testing laboratory to be addedto mailing lists. Mailing lists are valuable to nurses for automatic notification whenever protocols change or a newtestis added. The Sidebarabovelists someof the genetic teststhat are currently available.
Selected Genetic Tests Currently Available
Use Genetic Resources. Local university medical centers, commercial and university-based genetic centers, statehealth departments, and theCenters for Disease Control andPreventionmay assist in identifying genetic testing locations as well as identifying clinics andcounseling centers. The local media and the Internet may alsobe resources. However, information from these sources may not always be accurate or complete. Internet information is notpeerreviewed before beingposted. Parentor support groupinformation on theWebmay be valuable because affected families often become experts about 540 these conditions, especially if the genetic condition is rare. The topicof genetic resources has become so important that a separate article on thissubjectis included in thisissueof the Joumal (pp.515-516).
Learn the Ethical, Social, ana Legal Implications of a Genetic Condition or Test. Universally, families want to know why something has occurred as well as their risk for transmitting deleterious genes. However, discussing a genetic issue requires sensitivity. Familiesoften feel guilty if they have a condition that can transmita health risk to their offspring. It is importantto conveyan understanding of this while reinforcing that no one controls which genes are inherited or which genes are passed to children. It would be simple if everyonecould be referredto a geneticcounselor, but the reality is that most families will never be seen in a tertiary genetic center. Once again, the occupationalhealth nurse must learn to triage, be knowledgeable about a given condition, gather data, obtain a family history, complete a general assessment, and provide accurate, basic information that will prepare the employee for testing, evaluation, and counseling. Invariably, the occupational health nurse will be expected to review and reinforce the genetic information given by the physician or geneticist. Often, clients in crisis forget or do not hear the information provided. Assisting employees in understanding critical information may be the most important task for the occupationalhealth nurse. Occupational health professionals must provide basic genetic information in an objectivemanner.
In almost every instance, issues related to privacy and fear of discrimination arise. Occupational health nurses must know and enforce the policies related to privacy for any genetic laboratory receiving samples from the workplace. Who owns the sample? Who determines where the results are sent? What happens to any leftover samples? Is the test part of a study protocol? What kind of informed consent is required?
The greatest fearfor mostfamilies is whether thegenetic test will affect insurance coverage or future eligibility. Although some federal and state anti-discrimination laws exist, they do not fully protectthe population from discrimination. It is important to recognize that the concept of predisposition to disease as a reason to limit insurance or employment has no place in the era of molecular genetics. Everyone carries liability genes and is predisposed to more than one potential genetic risk. Everyone who has children passes on from 4 to 10 recessive lethal genesand numerous othergenesthat may have health consequences. No one controls these genes, so thereshouldbe no adverse consequences as a result.
SUMMARY OF GENETICS AND ITS EFFECT ON OCCUPATIONAL HEALTH
Advances in laboratory technology and discoveries in molecular genetics have made clinical genetics one of the most rapidly developing fields in health care. The progress made by the HumanGenome Project has improved recognition of genetic disorders and determined genetic variations that predispose employees to humandisease. Geneticknowledgeis an essential partof all branches of healthcare delivery and is particularly important in ascertaining health care needs and providing nursing care to families. In the future, occupational health nurses will be expected to recognize genetic problems, refer clients to appropriate health care providers and services, prepare clients for specialized testing, perform genetictherapies, assist with the ongoing care of clients with genetic disorders, and provide support and follow-up care to clients and theirfamilies.
Dr. Francis Collins, Director of the National Human Genome Research Institute (NHGRI), has often said that the problem is not whether the 3 billion base pairs can be found, but whether health care providers who are genetically literate can be created (Jenkins & Collins, 2003) . Genetic education seems to be the overriding challenge as tests and therapies are reaching provider offices, clinics, and the bedside. Occupational health nurses must provide leadership for employers and employees as the profession . enters the molecular genetic age.
3 The occupational health professional should be aware of rapidly changing genetic tests, be able to distinguish between screening and diagnostic modalities, be able to access genetic resources to find the latest protocols, and should consider the ethical, legal, and social implications of genetic testing inthe workplace.
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